|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acp |
1 No 1 Department of Obstetrics and Gynecology, Semmelweis University Budapest, Baross u. 27, 1088 Budapest, Hungary
2 Department of Histopathology, Birmingham Womens Hospital, Metchley Park Road, Edgbaston, Birmingham B15 2TG, UK
3 Department of Histopathology, Birmingham Womens Hospital
Correspondence to:
Dr T Marton
Department of Histopathology, Birmingham Womens Hospital, Metchley Park Road, Edgbaston, Birmingham B15 2TG, UK; Tamas.Marton{at}bwhct.nhs.uk
ABSTRACT
The human placenta is an underexamined organ. The clinical indications for placental examination have no gold standards. There is also inconsistency in the histological reports and the quality is variable. There is great interobserver variability concerning the different entities. Although there are still grey areas in clinicopathological associations, a few mainstream observations have now been clarified. The histopathological examination and diagnosis of the placenta may provide crucial information. It is possible to highlight treatable maternal conditions and identify placental or fetal conditions that can be recurrent or inherited. To achieve optimal benefit from placental reports, it is essential to standardise the method of placenta examination. This article summarises the clinical indications for placenta referral and the most common acknowledged clinicopathological correlations.
Abbreviations: AAA, arterioarterial anastomosis; AVA, arteriovenous anastomosis; IUGR, intrauterine growth restriction; VVA, venovenous anastomosis
Keywords: placenta; pathology; protocol; examination
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |